Science
Clinical-stage medical technology company focused on brain-computer interface (BCI) and neural engineering devices. Operates a vertically integrated technology stack including neural interface R&D, a MEMS foundry, ASIC design, software and clinical programs. Active in clinical trials for retinal prostheses and developing biohybrid neural interfaces, with headquarters in Alameda, California and additional offices in Research Triangle Park, NC and Paris, France.
Industries
Nr. of Employees
medium (51-250)
Science
Products
Wireless headstages for neural data acquisition and stimulation
Compact headstage hardware for neural stimulation and high-bandwidth wireless data acquisition designed for clinical and research use, supporting WiFi-based streaming and low-latency protocols.
High-density active neural probes
Active probes supporting hundreds of electrodes and integrated microLEDs for combined recording and optogenetic stimulation, available as stocked designs or custom layouts.
ASIC families for neural recording and microLED driving
Low-noise neural recording ASICs and microLED driver ASICs available in multiple channel/pixel densities for research and development use.
Probe adapters and interface boards
Adapters to convert probe connector formats to the platform protocol, enabling plug-and-play compatibility between probes and headstages.
Wireless headstages for neural data acquisition and stimulation
Compact headstage hardware for neural stimulation and high-bandwidth wireless data acquisition designed for clinical and research use, supporting WiFi-based streaming and low-latency protocols.
High-density active neural probes
Active probes supporting hundreds of electrodes and integrated microLEDs for combined recording and optogenetic stimulation, available as stocked designs or custom layouts.
ASIC families for neural recording and microLED driving
Low-noise neural recording ASICs and microLED driver ASICs available in multiple channel/pixel densities for research and development use.
Probe adapters and interface boards
Adapters to convert probe connector formats to the platform protocol, enabling plug-and-play compatibility between probes and headstages.
Services
Standard multi-project wafer runs and dedicated MEMS production, plus custom process development for non-standard materials and layer integrations; offerings span feasibility through volume production.
Hardware, probe fabrication, adapters, ASICs and software protocol to support neural recording, stimulation and BCI research; includes headstages for wireless acquisition and a documented neural signal protocol.
Clinical trial enrollment support and a patient registry for retinal disease therapies to identify candidates and support multi-site clinical studies and site activations.
Standard multi-project wafer runs and dedicated MEMS production, plus custom process development for non-standard materials and layer integrations; offerings span feasibility through volume production.
Hardware, probe fabrication, adapters, ASICs and software protocol to support neural recording, stimulation and BCI research; includes headstages for wireless acquisition and a documented neural signal protocol.
Clinical trial enrollment support and a patient registry for retinal disease therapies to identify candidates and support multi-site clinical studies and site activations.
Expertise Areas
- Brain-computer interface (BCI) development and clinical translation
- Neural engineering and high-channel-count neural recording
- MEMS fabrication and process development
- ASIC design for neural recording and optogenetic drivers
Key Technologies
- Biohybrid neural interfaces
- Subretinal photovoltaic retinal prosthesis
- Optogenetics
- MicroLED optogenetic stimulation
News & Updates
Series C financing reported at $230 million to fund commercialization of a retinal BCI implant and expansion of clinical and manufacturing infrastructure.
Announcement of CE marking and European commercial launch for a subretinal photovoltaic retinal implant authorized under EU medical device regulation.
Clinical trial results for the retinal implant were featured in the New England Journal of Medicine and related editorials; multi-center trial data reported improvements in visual acuity metrics.
Announcements describing the neural engineering product suite, foundry expansion and standard technologies to accelerate BCI research and device development.
Raised $230 million in Series C financing to support commercialization and clinical expansion.
Received CE marking for a retinal prosthesis enabling commercial availability across EU/EEA countries.
Series C financing reported at $230 million to fund commercialization of a retinal BCI implant and expansion of clinical and manufacturing infrastructure.
Announcement of CE marking and European commercial launch for a subretinal photovoltaic retinal implant authorized under EU medical device regulation.
Clinical trial results for the retinal implant were featured in the New England Journal of Medicine and related editorials; multi-center trial data reported improvements in visual acuity metrics.
Announcements describing the neural engineering product suite, foundry expansion and standard technologies to accelerate BCI research and device development.
Raised $230 million in Series C financing to support commercialization and clinical expansion.
Received CE marking for a retinal prosthesis enabling commercial availability across EU/EEA countries.